Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
المؤلفون المشاركون
Zhang, Weiwei
Teng, Mujian
Liu, Baochi
Liu, Qiling
Liu, Xin
Si, Yanhui
Li, Lei
المصدر
Gastroenterology Research and Practice
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-10-29
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Objective.
This study is aimed at examining the impact of repeated intraportal autologous bone marrow transfusion (ABMT) in patients with decompensated liver cirrhosis after splenectomy.
Methods.
A total of 25 patients with decompensated liver cirrhosis undergoing splenectomy were divided into ABMT and control groups.
The portal vein was cannulated intraoperatively using Celsite Implantofix through the right gastroomental vein.
Both groups were given a routine medical treatment.
Then, 18 mL of autologous bone marrow was transfused through the port in the patients of the ABMT group 1 week, 1 month, and 3 months after laminectomy, while nothing was given to the control group.
All patients were monitored for adverse events.
Liver function tests, including serum albumin (ALB), alanine aminotransferase (ALT), total bilirubin (TB), prothrombin activity (PTA), cholinesterase (CHE), α-fetoprotein (AFP), and liver stiffness measurement (LSM), were conducted before surgery and 1, 3, and 6 months after surgery.
Results.
Significant improvements in ALB, ALT, and CHE levels and decreased LSM were observed in the ABMT group compared with those in the control group (P<0.05).
TB and PTA improved in both groups but with no significant differences between the groups.
No significant changes were observed in AFP in the control group, but it decreased in the ABMT group.
No major adverse effects were noted during the follow-up period in the patients of either group.
Conclusions.
Repeated intraportal ABMT was clinically safe, and liver function of patients significantly improved.
Therefore, this therapy has the potential to treat patients with decompensated liver cirrhosis after splenectomy.
This trial was registered with the identification number of ChiCTR-ONC-17012592.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Zhang, Weiwei& Teng, Mujian& Liu, Baochi& Liu, Qiling& Liu, Xin& Si, Yanhui…[et al.]. 2018. Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy. Gastroenterology Research and Practice،Vol. 2018, no. 2018, pp.1-8.
https://search.emarefa.net/detail/BIM-1159610
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Zhang, Weiwei…[et al.]. Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy. Gastroenterology Research and Practice No. 2018 (2018), pp.1-8.
https://search.emarefa.net/detail/BIM-1159610
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Zhang, Weiwei& Teng, Mujian& Liu, Baochi& Liu, Qiling& Liu, Xin& Si, Yanhui…[et al.]. Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy. Gastroenterology Research and Practice. 2018. Vol. 2018, no. 2018, pp.1-8.
https://search.emarefa.net/detail/BIM-1159610
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1159610
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر